FOLTA, A., Ivana JEŽÍŠKOVÁ, Dana DVOŘÁKOVÁ, Nikola TOM, Martin ČULEN, Zdeňka KOSAŘOVÁ, Anna ĎURINÍKOVÁ, Petr CETKOVSKÝ, P. JINDRA, Tomáš SZOTKOWSKI, P. ŽÁK, Jiří MAYER and Zdeněk RÁČIL. Mutational analysis of 231 de novo AML patients below 60 years with curative therapy. In 22th Congress of EHA, Madrid, Španělsko, červen 2017, in Haematologica (2017); 102. 2017.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Mutational analysis of 231 de novo AML patients below 60 years with curative therapy
Authors FOLTA, A. (203 Czech Republic), Ivana JEŽÍŠKOVÁ (203 Czech Republic, belonging to the institution), Dana DVOŘÁKOVÁ (203 Czech Republic, belonging to the institution), Nikola TOM (203 Czech Republic, belonging to the institution), Martin ČULEN (703 Slovakia, belonging to the institution), Zdeňka KOSAŘOVÁ (203 Czech Republic, belonging to the institution), Anna ĎURINÍKOVÁ (703 Slovakia, belonging to the institution), Petr CETKOVSKÝ (203 Czech Republic, belonging to the institution), P. JINDRA (203 Czech Republic), Tomáš SZOTKOWSKI (203 Czech Republic), P. ŽÁK (203 Czech Republic), Jiří MAYER (203 Czech Republic, belonging to the institution) and Zdeněk RÁČIL (203 Czech Republic, belonging to the institution).
Edition 22th Congress of EHA, Madrid, Španělsko, červen 2017, in Haematologica (2017); 102, 2017.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30204 Oncology
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/17:00106914
Organization unit Faculty of Medicine
Keywords in English de novo; AML; therapy
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 17/5/2018 17:53.
Abstract
Mutational analysis of 231 de novo AML patients below 60 years with curative therapy, Mutational analysis of 231 de novo AML patients below 60 years with curative therapy
Links
MUNI/A/1106/2016, interní kód MUName: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit IV (Acronym: VýDiTeHeMA IV)
Investor: Masaryk University, Category A
NV15-25809A, research and development projectName: Národní program studia mutací a klonality leukemických buněk u pacientů s akutní myeloidní leukémií
PrintDisplayed: 27/4/2024 15:42